Vertex Pharmaceuticals Incorporated vs Novo Nordisk A/S
Market cap comparison over time
Vertex Pharmaceuticals Incorporated
$136.4B
Rank #122
Novo Nordisk A/S
$137.9B
Rank #118
Market Cap Over Time
Key Moments
- Vertex Pharmaceuticals Incorporated overtook Novo Nordisk A/S by 2005
- Novo Nordisk A/S overtook Vertex Pharmaceuticals Incorporated by 2007
Year-by-Year Comparison
| Year | Vertex Pharmaceuticals Incorporated | Novo Nordisk A/S | Leader |
|---|---|---|---|
| 2026 | $136.4B | $137.9B | Novo Nordisk A/S |
| 2025 | $115.1B | $152.9B | Novo Nordisk A/S |
| 2024 | $102.2B | $285.3B | Novo Nordisk A/S |
| 2023 | $103.3B | $315.6B | Novo Nordisk A/S |
| 2022 | $73.3B | $209.4B | Novo Nordisk A/S |
| 2021 | $55.7B | $161.6B | Novo Nordisk A/S |
| 2020 | $60.0B | $92.0B | Novo Nordisk A/S |
| 2019 | $55.6B | $81.6B | Novo Nordisk A/S |
| 2018 | $42.1B | $61.4B | Novo Nordisk A/S |
| 2017 | $38.0B | $67.2B | Novo Nordisk A/S |
| 2016 | $18.7B | $49.6B | Novo Nordisk A/S |
| 2015 | $31.9B | $75.8B | Novo Nordisk A/S |
| 2014 | $30.2B | $48.6B | Novo Nordisk A/S |
| 2013 | $18.9B | $36.5B | Novo Nordisk A/S |
| 2012 | $10.6B | $33.0B | Novo Nordisk A/S |
| 2011 | $8.4B | $23.3B | Novo Nordisk A/S |
| 2010 | $8.9B | $43.8B | Novo Nordisk A/S |
| 2009 | $10.9B | $22.7B | Novo Nordisk A/S |
| 2008 | $7.7B | $9.1B | Novo Nordisk A/S |
| 2007 | $5.9B | $22.1B | Novo Nordisk A/S |
| 2006 | $9.5B | $7.7B | Vertex Pharmaceuticals Incorporated |
| 2005 | $7.0B | $5.7B | Vertex Pharmaceuticals Incorporated |
| 2004 | $2.7B | $9.4B | Novo Nordisk A/S |
| 2003 | $2.6B | $7.5B | Novo Nordisk A/S |
| 2002 | $4.0B | $6.2B | Novo Nordisk A/S |
| 2001 | $6.2B | $10.3B | Novo Nordisk A/S |